A randomised, participant- and assessor-blinded, sham-controlled trial investigating acupuncture for disorders of gut-brain interaction in children (P-GAP).

BMJ OpenSep 22, 2026 (epub)

Ashish Chogle, Morris Gordon, Ruth McCarty et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized, participant- and assessor-blinded, sham-controlled trial investigates the efficacy of acupuncture for disorders of gut-brain interaction (DGBIs) in 96 children aged 8-17 years. The primary outcome is adequate pain relief, defined as a ≥30% reduction in mean abdominal pain severity on the 11-point Numerical Rating Scale from baseline to follow-up at weeks 12-14.

Key findings

  • Participants will be randomized 1:1 to receive either standardised acupuncture or sham acupuncture.
  • The primary outcome measures a ≥30% reduction in mean abdominal pain severity.
  • Secondary outcomes include changes in pain frequency and health-related quality of life.

Why it matters

DGBIs are prevalent in children and can lead to significant morbidity. Effective treatment options are limited, making the evaluation of acupuncture as a potential therapeutic approach important for improving patient outcomes.

Source

Published in BMJ Open. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.